BioAdaptives Inc.: 10-Q filed 2019-11-07
What BioAdaptives Inc. reported in its quarterly report filed 2019-11-07 (fiscal Q3 2019): 24 published measures, 69 facts as tagged in accession 0001640334-19-002191.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-07
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001640334-19-002191 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioAdaptives Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 14,419 | USD | |
| At 2018-12-31 | 110,059 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 785,293 | USD | |
| At 2018-12-31 | 803,800 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -770,874 | USD | |
| At 2019-06-30 | -739,167 | USD | |
| At 2019-03-31 | -580,296 | USD | |
| At 2018-12-31 | -693,741 | USD | |
| At 2018-09-30 | -520,599 | USD | |
| At 2018-06-30 | -315,293 | USD | |
| At 2018-03-31 | 26,406 | USD | |
| At 2017-12-31 | 3,505 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -54,905 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -142,331 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -648,598 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -1,070,472 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -91,720 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 2,076 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 8,779 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 35,660 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 376,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 32,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -4,662,321 | USD | |
| At 2018-12-31 | -4,519,990 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 23,198 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 65,198 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 85,270 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 179,785 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 14,419 | USD | |
| At 2018-12-31 | 110,059 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -48,172 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -145,750 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -159,373 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -182,438 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 785,293 | USD | |
| At 2018-12-31 | 715,989 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 46,880 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 155,495 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 213,269 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 480,115 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 12,783 | USD | |
| At 2018-12-31 | 49,857 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,641 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 6,520 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 435 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 2,259 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 18,829,109 | shares | |
| At 2018-12-31 | 18,096,169 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 3,889,564 | USD | |
| At 2018-12-31 | 3,824,412 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -54,905 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -142,331 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -648,598 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -1,070,472 | USD | 273 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -54,905 | USD | 92 |
| 2019-04-01 to 2019-06-30 | -179,871 | USD | 91 |
| 2019-01-01 to 2019-03-31 | 92,445 | USD | 90 |
| 2018-07-01 to 2018-09-30 | -648,598 | USD | 92 |
| 2018-04-01 to 2018-06-30 | -412,775 | USD | 91 |
| 2018-01-01 to 2018-03-31 | -9,099 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 16,808 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 41,167 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 66,465 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 135,236 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -9,666 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 6,644 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -435,329 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -590,357 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 37,074 | USD | 273 |
Inspect the source
- Entity
- BioAdaptives Inc. / CIK 0001575142
- Captured
- 2026-09-20T09:21:44.555Z
- SEC response SHA-256
7d70ec2a8370eeb33cd7c2482065b30cf052619c39bb59e21df838c8d2f96db2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001575142.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))